Feasibility of BRCA1/2 Testing of Formalin-Fixed and Paraffin-Embedded Pancreatic Tumor Samples: A Consecutive Clinical Series

Pancreatic ductal adenocarcinoma (PDAC) is an aggressive cancer, with most patients diagnosed at advanced stages. First-line treatment based on a combined chemotherapy (FOLFIRINOX or gemcitabine plus nab-paclitaxel) provides limited benefits. Olaparib, a PARP inhibitor, has been approved as maintena...

Descripción completa

Detalles Bibliográficos
Autores principales: Bruno, Rossella, Sensi, Elisa, Lupi, Cristiana, Giordano, Mirella, Bernardini, Laura, Vivaldi, Caterina, Fornaro, Lorenzo, Vasile, Enrico, Campani, Daniela, Fontanini, Gabriella
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8227758/
https://www.ncbi.nlm.nih.gov/pubmed/34200245
http://dx.doi.org/10.3390/diagnostics11061046

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8227758/
https://www.ncbi.nlm.nih.gov/pubmed/34200245
http://dx.doi.org/10.3390/diagnostics11061046

Ejemplares similares